John T Blake - Net Worth and Insider Trading

John T Blake Net Worth

The estimated net worth of John T Blake is at least $431 dollars as of 2024-11-10. John T Blake is the Senior Vice President, Finance of aTyr Pharma Inc and owns about 138 shares of aTyr Pharma Inc (ATYR) stock worth over $431. Details can be seen in John T Blake's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John T Blake has not made any transactions after 2018-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of John T Blake

John T Blake Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John T Blake owns 3 companies in total, including Second Sight Medical Products Inc (EYES) , aTyr Pharma Inc (ATYR) , and Vivani Medical Inc (VANI) .

Click here to see the complete history of John T Blake’s form 4 insider trades.

Insider Ownership Summary of John T Blake

Ticker	Comapny	Transaction Date	Type of Owner
EYES	Second Sight Medical Products Inc	2019-02-19	Chief Financial Officer
ATYR	aTyr Pharma Inc	2018-02-08	Vice President & Finance
VANI	Vivani Medical Inc	2019-02-19	Chief Financial Officer

John T Blake Latest Holdings Summary

John T Blake currently owns a total of 1 stock. John T Blake owns 138 shares of aTyr Pharma Inc (ATYR) as of February 8, 2018, with a value of $431.

Latest Holdings of John T Blake

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ATYR	aTyr Pharma Inc	2018-02-08	138	3.12	431

Holding Weightings of John T Blake

John T Blake Form 4 Trading Tracker

According to the SEC Form 4 filings, John T Blake has made a total of 0 transactions in aTyr Pharma Inc (ATYR) over the past 5 years. The most-recent trade in aTyr Pharma Inc is the sale of 100 shares on February 8, 2018, which brought John T Blake around $4,767.

Insider Trading History of John T Blake

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John T Blake Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John T Blake Ownership Network

Ownership Network List of John T Blake

No Data

Ownership Network Relation of John T Blake

John T Blake Owned Company Details

What does Second Sight Medical Products Inc do?

Who are the key executives at Second Sight Medical Products Inc?

John T Blake is the Chief Financial Officer of Second Sight Medical Products Inc. Other key executives at Second Sight Medical Products Inc include Chief Medical Officer Lisa Ellen Porter , Chief Business Officer Donald Dwyer , and COO Truc Le .

Second Sight Medical Products Inc (EYES) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Second Sight Medical Products Inc (EYES) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Second Sight Medical Products Inc (EYES) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Second Sight Medical Products Inc (EYES)'s detailed insider trading history can be found in Insider Trading Tracker table.

Second Sight Medical Products Inc Insider Transactions

No Available Data

What does aTyr Pharma Inc do?

Who are the key executives at aTyr Pharma Inc?

John T Blake is the Vice President & Finance of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , Chief Medical Officer Sanjay Shukla , and See Remarks Nancy Krueger .

aTyr Pharma Inc (ATYR) Insider Trades Summary

Over the past 18 months, John T Blake made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 3,410 shares made by Jill Marie Broadfoot , and a net purchase of 100,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

aTyr Pharma Inc Insider Transactions

No Available Data

What does Vivani Medical Inc do?

Who are the key executives at Vivani Medical Inc?

John T Blake is the Chief Financial Officer of Vivani Medical Inc. Other key executives at Vivani Medical Inc include Chief Business Officer Donald Dwyer , director & 10 percent owner Gregg Williams , and CFO Brigid Makes .

Vivani Medical Inc (VANI) Insider Trades Summary

Over the past 18 months, John T Blake made no insider transaction in Vivani Medical Inc (VANI). Other recent insider transactions involving Vivani Medical Inc (VANI) include a net purchase of 727,608 shares made by Gregg Williams , a net purchase of 40,000 shares made by Donald Dwyer , and a net purchase of 15,000 shares made by Brigid Makes .

In summary, during the past 3 months, insiders sold 0 shares of Vivani Medical Inc (VANI) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Vivani Medical Inc (VANI) were sold and 792,608 shares were bought by its insiders, resulting in a net purchase of 792,608 shares.

Vivani Medical Inc (VANI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vivani Medical Inc Insider Transactions

No Available Data

John T Blake Mailing Address

Above is the net worth, insider trading, and ownership report for John T Blake. You might contact John T Blake via mailing address: C/o Second Sight Medical Products, Inc., 12744 San Fernando Road, Suite 400, Sylmar Ca 91342.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.